CD20 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD20 antibody, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma [Phase 2]